Sharda Cropchem Ltd. · NSE:SHARDACROP
Sharda Cropchem — Q1 FY16 Earnings Presentation
17 slides from Sharda Cropchem's earnings presentation, August 2015
Slide 1: First Quarter FY16 Results Update
FIRST QUARTER FY16 RESULTS UPDATE AUGUST 2015
Slide 2: Disclaimer
DISCLAIMER This presentation and the following discussion may contain “forward looking statements” by Sharda Cropchem Limited (“Sharda” or the Company) that are not historical in nature. These forward looking statements, which may include statements relating to future results of operations, financia
Slide 3: Discussion Summary
DISCUSSION SUMMARY Q1 FY16 Results Highlights Q1 FY16 Consolidated Financials About Us Business Model Business Strategy & Outlook 3
Slide 4: Q1 FY16 Results: Key Highlights
Q1 FY16 RESULTS: KEY HIGHLIGHTS Q1 FY16 YoY ANALYSIS REVENUES & GROSS MARGIN EBITDA & EBITDA MARGIN * PAT & PAT MARGIN 36.1% 32.5% 15.9% 12.9% 22.7% 18.3% 2,710.4 2,794.0 614.3 510.6 431.2 360.3 3.1 % - 16.9 % - 16.4 % Q1 FY15 Q1 FY16 Q1 FY15 Q1 FY16 Q1 FY15 Q1 FY16 Revenues Gross Margin % EBITDA EB
Slide 5: Q1 FY16 Results: Key Highlights
Q1 FY16 RESULTS: KEY HIGHLIGHTS FINANCIAL UPDATE - • Q1 FY16 Total Revenues grew 3.1% YoY to Rs. 2,794.0 mn primarily driven by volume growth of 14.1%, largely offset by unfavourable currency movement (majorly Euro-Dollar depreciation) leading to decline of 5.6% and lower realisations leading to dec
Slide 6: Q1 FY16 Results: Revenue Analysis
Q1 FY16 RESULTS: REVENUE ANALYSIS Q1 FY16 YoY % CHANGE IN REVENUE FROM OPERATIONS Volumes Impact 14.1% Price/Product/Region Mix Impact 3.2% -5.3% Currency Impact -5.6% 6
Slide 7: Q1 FY16 Results: Revenue Analysis
Q1 FY16 RESULTS: REVENUE ANALYSIS AGROCHEMICALS VS. NON-AGROCHEMICALS GEOGRAPHICAL PRESENCE – AGROCHEMICAL SALES Total 2,704.5 2,790.4 Total 2,236.4 2,348.7 Revenues Agrochemical 10.8% 9.4% 17.3% 15.8% From Revenues 13.4% 17.2% Operations 22.4% 30.2% 82.7% 84.2% 49.6% 47.0% Q1 FY15 Q1 FY16 Q1 FY15 Q
Slide 8: Update on Registrations
UPDATE ON REGISTRATIONS REGISTRATIONS AS ON REGISTRATIONS - FORMULATIONS REGISTRATIONS PIPELINE AS ON 30 - JUNE - 2015: 1,488 VS. ACTIVE INGREDIENTS 30 - JUNE - 2015: 726 204 333 123 395 164 77 1,284 104 683 335 Jun-15 Jun-15 Jun-15 Europe NAFTA LATAM RoW Formulations AIs Europe NAFTA LATAM RoW REGI
Slide 9: Consolidated Profit & Loss Statement
CONSOLIDATED PROFIT & LOSS STATEMENT Particulars (In Rs Mn) Q1 FY16 Q1 FY15 YoY % Q4 FY15 QoQ % FY15 FY14 YoY % Revenue from Operations 2,790.4 2,704.5 3.2% 3,405.2 -18.1% 10,610.6 7,903.7 34.2% Other Operating Income 3.6 5.9 -38.7% 3.3 8.8% 47.7 7.7 517.1% Total Revenues 2,794.0 2,710.4 3.1% 3,408.
Slide 10: Consolidated Balance Sheet
CONSOLIDATED BALANCE SHEET Particulars (In Rs Mn) FY15 FY14 Particulars (In Rs Mn) FY15 FY14 Share Capital 902.2 902.2 Non-current assets Fixed assets 879.7 638.2 Reserves & Surplus 5,642.9 4,655.2 Intangible assets under development 1,487.8 1,334.8 Shareholder's Funds 6,545.1 5,557.4 Goodwill on co
Slide 11: About Us: Company Overview
ABOUT US: COMPANY OVERVIEW Sharda Cropchem Limited is a global crop protection chemical company largely operating across Europe, NAFTA and Latin America across fungicides, herbicides and insecticides. Sharda operates with an asset light business model focused on identification and registration o
Slide 12: About Us: Our Presence
ABOUT US: OUR PRESENCE Agrochemical Operations Diversified business operations across the globe leading to reduced risk of adverse market and seasonal conditions 12
Slide 13: About Us: Shareholding Structure
ABOUT US: SHAREHOLDING STRUCTURE Market Data As on 05.08.15 (BSE) Share Price Performance Current Price Market capitalization (Rs Mn) 31,487.0 400.0 Rs 349.0 Price (Rs.) 349.0 300.0 No. of shares outstanding (Mn) 90.2 200.0 Listing Price Rs 156.0 Face Value (Rs.) 10.0 100.0 52 week High-Low (Rs.) 40
Slide 14: About Us: Financial Summary
ABOUT US: FINANCIAL SUMMARY In Rs Mn REVENUE FROM OPERATIONS EBITDA & EBITDA Margin PAT & PAT Margin CAGR: 24.5% CAGR: 20.7% CAGR: 31.3% 10,611 18.2% 20.0% 18.0% 19.5% 16.1% 9.4% 11.2% 10.8% 14.1% 11.6% 7,777 7,904 6,135 1,111 1,230 1,543 1,713 4,418 1,225 1,400 844 687 806 414 FY11 FY12 FY13 FY14 F
Slide 15: Differentiated Business Model: Asset Light Model
DIFFERENTIATED BUSINESS MODEL: ASSET LIGHT MODEL Agrochemical Value Chain Sharda’s Operating Area Basic & Active Formulation & Marketing & Applied Identification Registration Ingredient Packaging Distribution Research Manufacturing Sharda’s Model: Traditional Model: ASSET LIGHT BUSINESS MODEL Demand
Slide 16: Business Strategy & Outlook
BUSINESS STRATEGY & OUTLOOK Leverage market presence and execution capabilities. Forward Integration - Adopt the factory-to-farmer approach & be a one-stop solution provider. Build own Sales Force Strategy on ground in Mexico, Colombia, South Africa & India . Expand & Strengthen Expand geogr
Slide 17: Thank You
FOR FURTHER QUERIES: THANK YOU Mr. Gautam Arora Mr. Ammeet Sabarwal / Mr. Nilesh Dalvi Chief Financial Officer IR Consultant Email: garora@shardaintl.com Email: ammeet.sabarwal@dickensonir.com Contact No: +91 22 6678 2800 nilesh.dalvi@dickensonir.com Contact No: +91 9819576873 / 9819289131 17